Retraction Note: Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene (10.1023/a:1024921329885);Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene

Molecular and Cellular Biochemistry

Volumn 250, Issue 1-2, 2003, Pages 151-158

  Ngumbela, Kholiswa C ^a   Sack, Michael N ^a   Essop, M Faadiel ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Fatty acid oxidation; Gene expression; Hypobaric hypoxia; Transcriptional regulation

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTION FACTOR SP3;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUSION; HYPOBARISM; HYPOXIA; MALE; METABOLISM; MOUSE; NONHUMAN; PROMOTER REGION; REPORTER GENE; STATISTICAL ANALYSIS; STEADY STATE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALIA; APOGON BRACHYGRAMMUS; BACTERIA (MICROORGANISMS); EUKARYOTA; FELIS CATUS; MUS MUSCULUS;

EID: 0042386056     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-023-04898-7     Document Type: Erratum

References (33)

1. Taegtmeyer H, Hems R, Krebs HA: Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186: 701-711, 1980
2. Barger PM, Kelly DP: Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms. Am J Med Sci 318: 36-42, 1999
3. Depre C, Vanoverschelde JL, Taegtmeyer H: Glucose and the heart. Circulation 99: 578-588, 1999
4. Holden JE, Stone CK, Clark CM, Brown WD, Nickles RJ, Stanley C, Hochachka PW: Enhanced cardiac metabolism of plasma glucose in high-altitude natives: Adaptation against chronic hypoxia. J Appl Physiol 79: 222-228, 1995
5. Young ME, Laws FA, Goodwin GW, Taegtmeyer H: Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem 276: 44390-44395, 2001
6. Hasenfuss G, Maier LS, Hermann HP, Luers C, Hunlich M, Zeitz O, Janssen PM, Pieske B: Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium. Circulation 105: 194-199, 2002
7. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ: Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA 91: 6496-6500, 1994
8. Semenza GL, Roth PH, Fang HM, Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763, 1994
9. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537, 1996
10. Discher DJ, Bishopric NH, Wu X, Peterson CA, Webster KA: Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem 273: 26078-26093, 1998
11. Abdel-aleem S, St Louis J, Hendrickson SC, El-Shewy HM, El-Dawy K, Taylor DA, Lowe JE: Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia. Mol Cell Biochem 180: 95-103, 1998
12. Rumsey WL, Abbott B, Bertelsen D, Mallamaci M, Hagan K, Nelson D, Erecinska M: Adaptation to hypoxia alters energy metabolism in rat heart. Am J Physiol 276: H71-80, 1999
13. 2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 276: 27605-27612, 2001
14. Razeghi P, Young ME, Abbasi S, Taegtmeyer H: Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. Biochem Biophys Res Commun 287: 5-10, 2001
15. Disch DL, Rader TA, Cresci S, Leone TC, Barger PM, Vega R, Wood PA, Kelly DP: Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: Role for nuclear receptors in cardiac and brown adipose tissue expression. Mol Cell Biol 16: 4043-4051, 1996
16. Sack MN, Disch DL, Rockman HA, Kelly DP: A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA 94: 6438-6443, 1997
17. Smith RM, McCarthy J, Sack MN: TNF alpha is required for hypoxia-mediated right ventricular hypertrophy. Mol Cell Biochem 219: 139-143, 2001
18. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid enzyme encoding gene expression is downregulated in the failing heart. Circulation 94: 2837-2842, 1996
19. Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89: 1191-1198, 2001
20. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP: The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91: 11012-11016, 1994
21. Werner JC, Sicard RE: Lactate metabolism of isolated, perfused fetal, and newborn pig hearts. Pediatr Res 22: 552-556, 1987
22. Lopaschuk GD, Collins-Nakai RL, Itoi T: Developmental changes in energy substrate use by the heart. Cardiovasc Res 26: 1172-1180, 1992
23. Makinde AO, Kantor PF, Lopaschuk GD: Maturation of fatty acid and carbohydrate metabolism in the newborn heart. Mol Cell Biochem 188: 49-56, 1998
24. Kantor PF, Robertson MA, Coe JY, Lopaschuk GD: Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol 33: 1724-1734, 1999
25. 31P magnetic resonance spectroscopy of the Sherpa heart: A phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci USA 93: 1215-1220, 1996
26. Hochachka PW: Mechanism and evolution of hypoxia-tolerance in humans. J Exp Biol 201: 1243-1254, 1998
27. Singh N, Dhalla AK, Seneviratne C, Singal PK: Oxidative stress and heart failure. Mol Cell Biochem 147: 77-81, 1995
28. Remondino A, Rosenblatt-Velin N, Montessuit C, Tardy I, Papageorgiou I, Dorsaz PA, Jorge-Costa M, Lerch R: Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. J Mol Cell Cardiol 32: 2025-2034, 2000
29. Majello B, De Luca P, Lania L: Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272: 4021-4026, 1997
30. Kennett SB, Moorefield KS, Horowitz, JM: Sp3 represses gene expression via the titration of promoter-specific transcription factors. J Biol Chem 277: 9780-9789, 2002
31. Carter ME, Gulick T, Raisher BD, Caira T, Ladias JAA, Moore DD, Kelly DP: Hepatocyte nuclear factor-4 activates medium chain acyl-CoA dehydrogenase gene transcription by interacting with a complex regulatory element. J Biol Chem 268: 13805-13810, 1993
32. Carter ME, Gulick TG, Moore DD, Kelly DP: A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs. Mol Cell Biol 14: 4360-4372, 1994
33. Leone TC, Cresci S, Carter ME, Zhang Z, Lala DS, Strauss AW, Kelly DP. The human medium chain acyl-CoA dehydrogenase gene promoter consists of a complex arrangement of nuclear receptor elements and Sp1 binding sites. J Biol Chem 270: 16309-16314, 1995